Literature DB >> 7813820

Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients.

C Bjørbaek1, T A Vik, S M Echwald, P Y Yang, H Vestergaard, J P Wang, G C Webb, K Richmond, T Hansen, R L Erikson.   

Abstract

Complementary DNA encoding three catalytic subunits of protein phosphatase 1 (PP1 alpha, PP1 beta, and PP1 gamma) and the insulin-stimulated protein kinase 1 (ISPK-1) was analyzed for variations in the coding regions related to insulin-resistant glycogen synthesis in skeletal muscle of 30 patients with non-insulin-dependent diabetes mellitus (NIDDM). The human ISPK-1 cDNA was cloned from T-cell leukemia and placental cDNA libraries and mapped to the short arm of the human X chromosome. Single-strand conformation polymorphism (SSCP) analysis identified a total of six variations in the coding regions of the PP1 genes: two in PP1 alpha at codons 90 and 255; one in PP1 beta at codon 67; and three in PP1 gamma at codons 11,269, and 273, respectively. All were, however, silent single nucleotide substitutions. SSCP analysis of the ISPK-1 gene identified one silent polymorphism at codon 266 and one amino acid variant at codon 38 (Ile-->Ser). This variant was primarily found in one male NIDDM patient. This subject, however, did not exhibit an impairment of muscle insulin-stimulated glycogen synthase activation. No significant differences were found in mRNA levels in muscle of the four genes between 15 NIDDM patients and 14 healthy subjects. Our findings suggest that 1) genetic abnormalities in the coding regions of PP1 alpha, PP1 beta, PP1 gamma, and ISPK-1 are unlikely to be frequently occurring causes of the reduced insulin-stimulated activation of the glycogen synthesis in muscle from the analyzed group of NIDDM patients; 2) the mRNA levels of PP1 alpha, PP1 beta, PP1 gamma, and ISPK-1 are normal in muscle from the NIDDM patients; and 3) putative inherited defects in insulin-stimulated activation of muscle glycogen synthesis in patients with insulin-resistant NIDDM may be located further upstream of ISPK-1 in the insulin action cascade.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7813820     DOI: 10.2337/diab.44.1.90

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Characterization of hearing loss in aged type II diabetics.

Authors:  Susan T Frisina; Frances Mapes; SungHee Kim; D Robert Frisina; Robert D Frisina
Journal:  Hear Res       Date:  2005-11-23       Impact factor: 3.208

Review 2.  Insulin action in skeletal muscle from patients with NIDDM.

Authors:  J R Zierath; A Krook; H Wallberg-Henriksson
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Construction of a YAC contig and an STS map spanning 3.6 megabase pairs in Xp22.1.

Authors:  D Trump; G Pilia; P H Dixon; C Wooding; R Thakrar; S E Leigh; R Nagaraja; M P Whyte; D Schlessinger; R V Thakker
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

4.  Unusual splice-site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin-Lowry syndrome.

Authors:  Maria Zeniou; Solange Pannetier; Jean-Pierre Fryns; André Hanauer
Journal:  Am J Hum Genet       Date:  2002-04-25       Impact factor: 11.025

5.  Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice.

Authors:  S D Dufresne; C Bjørbaek; K El-Haschimi; Y Zhao; W G Aschenbach; D E Moller; L J Goodyear
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

6.  Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.

Authors:  H Vestergaard; C Bjørbaek; T Hansen; F S Larsen; D K Granner; O Pedersen
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 7.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

8.  Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.

Authors:  S Jacquot; K Merienne; D De Cesare; S Pannetier; J L Mandel; P Sassone-Corsi; A Hanauer
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

9.  Rapid immunoblot and kinase assay tests for a syndromal form of X linked mental retardation: Coffin-Lowry syndrome.

Authors:  K Merienne; S Jacquot; E Trivier; S Pannetier; A Rossi; C Scott; A Schinzel; C Castellan; W Kress; A Hanauer
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

Review 10.  Coffin-Lowry syndrome: clinical and molecular features.

Authors:  A Hanauer; I D Young
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.